Navigation Links
Cepheid Receives FDA Market Authorization for Xpert MTB/RIF
Date:7/25/2013

SUNNYVALE, Calif., July 25, 2013 /PRNewswire/ --Cepheid (Nasdaq: CPHD) today announced it has received market authorization from the U.S. Food & Drug Administration (FDA) for its Xpert® MTB/RIF test. The review decision was based on the de novo 510(k) review process, which allows novel products without predicates to be down-classified and brought to market. Xpert MTB/RIF is designed for the rapid molecular detection of Mycobacterium tuberculosis complex (MTB-complex) DNA and, in specimens where MTB-complex DNA is detected, Xpert MTB/RIF also detects rifampin-resistance associated mutations of the rpoB gene. 

"With results available to clinicians in approximately 2 hours instead of weeks, the dramatic impact of Xpert MTB/RIF on identifying TB positive patients and optimizing their drug therapy has been well documented outside of the U.S.1," said John Bishop, Cepheid's Chairman and Chief Executive Officer. "Now, U.S. clinicians can leverage those same transformative results not only for the detection of TB (tuberculosis), but also for detecting whether the strain may be multidrug-resistant, requiring more intensive drug therapy."

Designed for use on Cepheid's GeneXpert® Systems, Xpert MTB/RIF not only detects the presence of MTB-complex DNA, but also mutations associated with resistance to rifampin, a critical first-line drug for treatment of the disease and a reliable surrogate marker of strains that may be multidrug-resistant (MDR-TB). Patients with multidrug-resistant TB need more intensive and prolonged therapy. Xpert MTB/RIF will enable U.S. clinicians to significantly improve patient outcomes by providing rapid results that guide therapy decisions early in the course of disease, not 6 weeks later as is the case with standard laborat
'/>"/>

SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cepheid and American Lung Association Partner for Tuberculosis Awareness in U.S.
2. Cepheid Schedules 2013 First Quarter Results Announcement And Webcast
3. Cepheid Reports Fourth Quarter And Full Year 2012 Results
4. Cepheid Announces Executive Vice President Emerging Markets
5. Cepheid to Webcast Upcoming Financial Presentations
6. Imprimis Pharmaceuticals, Inc. Receives Institutional Review Board (IRB) Approval for its Phase III Clinical Trial Protocol; Phase III Clinical Trial to Begin in 3Q 2013
7. RxSafetyMatters Receives 2013 Communicator Award for its Mobile Site
8. Perrigo Receives FDA Tentative Approval For Generic Equivalent To Prandin(R)
9. Elekta Receives CE Marking for Clarity 4D Monitoring
10. SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
11. Bison Stainless Tube Receives ISO 9001:2008 Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... Cardiac Science Corporation (Nasdaq: CSCX ), a ... ) and diagnostic cardiac monitoring devices, announced today it appointed ... of directors. Andrews replaces long-time board member Jue-Hsien Chern, Ph.D., ... The total number of directors remains at six. , ...
... (Nasdaq: ITMN ) today announced results from operations for the ... InterMune reported a net loss for the third quarter of ... net loss of $14.0 million, or $0.36 per share, in the ... and President of InterMune, said, "The third quarter and recent weeks ...
Cached Medicine Technology:Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 2Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 3Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 4Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 2InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 3InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 4InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 5InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 6InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 7InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 8InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 9InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 10InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 11InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 12InterMune Reports Third Quarter 2009 Financial Results and Business Highlights 13
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... in those who listened just a few hours a day ... for a few hours a day can help boost a ... study of 54 patients who,d suffered a stroke of the ... who listened to music for a few hours a day ...
... Does exposure of baby boys -- in utero or in ... natural estrogens, predispose them to prostate cancer later in life? ... Illinois at Chicago researcher and her colleague aims to answer ... it may occur. , Gail Prins, professor of urology at ...
... This release is available in French . , ... battle in the fight against age-related macular degeneration, or AMD, ... international team, led by researchers at Sainte-Justine Hospital and the ... the dry form of AMD. , In the February ...
... an active material could be used to remove toxic ... much more effectively and at lower cost than conventional ... current issue of the International Journal of Nanotechnology. , ... Wark Research Institute, at the University of South Australia, ...
... Feb. 20 HIV/AIDS is still a,taboo topic among ... to change this. For Dinah Ayna, talking about HIV ... is a challenging, yet a rewarding,part of her daily ... are 3.5 million Arab,Americans in the U.S. One-third live ...
... 20 LifeSync Corporation is,pleased to announce the ... of Research and Development. Dr. Phelps, who will ... responsible for leading all,product design and development at ... Georgia Electronic Design Center (GEDC),at the Georgia Institute ...
Cached Medicine News:Health News:Music Therapy Improves Stroke Outcomes 2Health News:Grant to study if early BPA exposure leads to late prostate cancer 2Health News:AMD discovery: New hope for treatment of vision loss 2Health News:Cleaner water through nanotechnology 2Health News:Breaking Down Barriers: A Woman's Path to Reducing HIV Stigma in the Arab American Community 2Health News:LifeSync Hires Dr. Mark Phelps to Lead Research & Development 2
... The Nightingale Monitoring System™ expands hospital-grade monitoring ... of subacute care and disease state management. ... ability to encompass a full range of ... patients inside the hospital, to periodic monitoring ...
... FlexNet adds wireless capability to ... This expands the Flexible Monitoring concept ... patient information from anywhere to anywhere. ... ambulatory wireless monitors and hardwired and ...
... Propaq CS makes the ... Propaq CS even more ... Symbol Technologies, the Wireless ... wireless ethernet Local Area ...
... Welch Allyn Vital Signs Monitor ... clinical areas that don't require ... to use, each monitor comes ... and optional features include Nellcor ...
Medicine Products: